Local immune responsiveness following intravaginal challenge with Candida antigen in adult women at different stages of the menstrual cycle

Medical Mycology

Volumn 41, Issue 2, 2003, Pages 97-109

  Fidel Jr , P L ^a   Barousse, M ^a   Lounev, V ^a   Espinosa, T ^a   Chesson, R R ^a   Dunlap, K ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Candida albicans; Cytokines; Menstrual cycle; Recurrent vulvovaginal candidiasis; Vaginal immunity

Indexed keywords

ANTIGEN; CYTOKINE; HISTAMINE; IMMUNOGLOBULIN E; PROSTAGLANDIN; FUNGUS ANTIGEN; PROSTAGLANDIN E2;

ADULT; ARTICLE; CANDIDA ALBICANS; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOSTIMULATION; MENSTRUAL CYCLE; NORMAL HUMAN; PROTEIN BLOOD LEVEL; VAGINA SECRETION; BIOSYNTHESIS; FEMALE; IMMUNOLOGY; MICROBIOLOGY; MUCOSAL IMMUNITY; RECURRENT DISEASE; VAGINA; VAGINA CANDIDIASIS;

CANDIDA; CANDIDA ALBICANS;

ANTIGENS, FUNGAL; CANDIDA ALBICANS; CANDIDIASIS, VULVOVAGINAL; CYTOKINES; DINOPROSTONE; FEMALE; HISTAMINE; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN E; MENSTRUAL CYCLE; RECURRENCE; VAGINA;

EID: 0142170029     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1080/mmy.41.2.97.109     Document Type: Article

References (30)

1. Hurley R, De Louvois J. Candida vaginitis. Postgrad Med J 1979; 55: 645-647.
2. Sobel JD. Pathogenesis and epidemiology of vulvovaginal candidiasis. Ann NY Acad Sci. 1988; 544: 547-557.
3. Sobel JD. Pathogenesis and treatment of recurrent vulvovaginal candidiasis. Clin Infect Dis 1992; 14(suppl 1): S148-S153.
4. Fidel PL, Jr., Sobel JD. Immunopathogenesis of recurrent vulvovaginal candidiasis. Clin Microbiol Rev 1996; 9: 335-48.
5. Witkin SS. Immunology of recurrent vaginitis. Am J Reprod Immunol Microbiol 1987; 15: 34-37.
6. Cenci E, Mencacci A, Spaccapelo R, et al. T helper cell type 1 (Th1)- and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development. J Infect Dis 1995; 171: 1279-1288.
7. Romani L, Mencacci A, Cenci E, et al. CD+ subset expression in murine candidiasis. J Immunol 1993; 150: 925-931.
8. Romani L, Mocci S, Bietta C, Lanfaloni L, Puccetti P, Bistoni F. Th1 and Th2 cytokine secretion patterns in murine candidiasis: association of Th1 responses with acquired resistance. Infect Immun 1991; 59: 4647-4654.
9. Fong IW, McCleary P, Read S. Cellular immunity of patients with recurrent or refractory vulvovaginal moniliasis. Am J Obstet Gynecol 1992; 166: 887-890.
10. Syverson RA, Buckley H, Gibian J, Ryan JJM. Cellular and humoral immune status in women with chronic Candida vaginitis. Am J Obstet Gynecol 1979; 134: 624-627.
11. Mendling W, Koldovsky U. Investigations by cell-mediated immunologic tests and therapeutic trials with thymopentin in vaginal mycoses. Infect Dis Obstet Gynecol 1996; 4: 225-231.
12. Fidel PL, Jr., Lynch ME, Redondo-Lopez V, Sobel JD, Robinson R. Systemic cell-mediated immune reactivity in women with recurrent vulvovaginal candidiasis (RVVC). J Infect Dis 1993; 168: 1458-1465.
13. Fidel PL, Jr., Lynch ME, Conaway DH, Tait L, Sobel JD. Mice immunized by primary vaginal C. albicans infection develop acquired vaginal mucosal immunity. Infect Immun 1995; 63: 547-553.
14. Fidel PL, Jr., Lynch ME, Sobel JD. Circulating CD4 and CD8 T cells have little impact on host defense against experimental vaginal candidiasis. Infect Immun 1995; 63: 2403-2408.
15. Fidel PL, Jr., Luo W, Chabain J, Wolf NA, Van Buren E. Use of cellular depletion analysis to examine circulation of immune effector function between the vagina and the periphery. Infect Immun 1997; 65: 3939-3943.
16. Fidel PL, Jr., Luo W, Steele C, Chabain J, Baker M, Wormley FL. Analysis of vaginal cell populations during experimental vaginal candidiasis. Infect Immun 1999; 67: 3135-3140.
17. Taylor BN, Saavedra M, Fidel PL, Jr. Local Th1/Th2 cytokine production during experimental vaginal candidiasis. Med Mycol 2000; 38: 419-431.
18. Wormley FL, Jr., Chaiban J, Fidel PL, Jr. Cell adhesion molecule and lymphocyte activation marker expression during experimental vaginal candidiasis. Infect Immun 2001; 69: 5072-5079.
19. Fidel PL, Jr., Ginsburg KA, Cutright JL, et al. Vaginal-associated immunity in women with recurrent vulvovaginal candidiasis: Evidence for vaginal Th1-type responses following intravaginal challenge with Candida antigen. J Infect Dis 1997; 176: 728-739.
20. Mathur S, Virella G, Koistinen J, Horger EO, Mahvi TA, Fudenberg HH. Humoral immunity in vaginal candidiasis. Infect Immun 1977; 15: 287-294.
21. Romani L, Puccetti P, Bistoni F. Romagnani S, (Eds). Biological role of Th cell subsets in candidiasis In: Th1 and Th2 cells in health and disease. Karger, Farmington, CT, 1996;. pp. 114-137.
22. Ginsburg KA, Wolf NA, Fidel PL, Jr. Potential effects of midcycle cervical mucus on mediators of immune reactivity. Fertil Steril 1997; 67: 46-50.
23. Fidel PL, Jr., Lynch ME, Sobel JD. Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis. Infect Immun 1993; 61: 1990-1995.
24. Steele C, Ratterree M, Fidel PL, Jr. Differential susceptibility to experimental vaginal candidiasis in macaques. J Infect Dis 1999; 180: 802-810.
25. DeBernardis F, Santoni G, Boccanera M, et al. Local anticandidal immune responses in a rat model of vaginal infection by and protection against Candida albicans. Infect Immun 2000; 68: 3297-3304.
26. Steele C, Ozenci H, Luo W, Scott M, Fidel PL, Jr. Growth inhibition of Candida albicans by vaginal cells from naive mice. Med Mycol 1999; 37: 251-260.
27. Barousse M, Steele C, Dunlap K, Espinosa T, Boikov D, Sobel J.D. Growth Inhibition of Candida albicans by human vaginal epithelial cells. J Infect Dis 2001; 184: 1489-1493.
28. Cohen MS, Cannon JG, Jerse AE, Charniga LM, Isbey SF, and Whicker LG. Human experimentation with Neisseria gonorrhoeae: rationale, methods, and implications for the biology of infection and vaccine development. J Infect Dis 1994; 169: 532-537.
29. Al-Tawfig JA, Palmer KL, Chen C, Haley JC, Katz BP, Hood AF, Spinola SM. Experimental infection of human volunteers with Haemophilus ducreyi does not confer protection against subsequent challenge. J Infect Dis 1999; 179: 1283-1287.
30. Al-Harthi L, Wright DJ, Anderson DJ, et al. The impact of the ovulatory cycle in cytokine production: The evaluation of systemic cervicovaginal and salivary compartments. J Interferon Cytokine Res 2000; 20: 719-724.